SEC Form 4 · accession 0001415889-19-000317
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin M Farr
Officer — CHIEF FINANCIAL OFFICER
Period of report
Mar 12, 2019
Accepted (ET)
Mar 13, 2019 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2019 | P | 7,300 | $3.62 | A | 23,000 | D |
Table II — derivative securities
No Table II lines on this filing.